Diagnostic hapten-carrier conjugates BSA-Sodium valproate (VPA), OVA-Sodium valproate (VPA), KLH-Sodium valproate (VPA) for EpilepsyVPAdetection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Valproate (VPA) and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches. They are useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. They can be given intravenously or by mouth, and the tablet forms exist in both long- and short-acting formulations.

Genemedi produces core diagnostic ingredients for test of Epilepsy and related syndrome.

GeneMedi offers Diagnostic hapten-carrier conjugates BSA-Sodium valproate (VPA), OVA-Sodium valproate (VPA), KLH-Sodium valproate (VPA) for Epilepsy VPA detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Epilepsy test are suitable for in functional ELISA, and other immunoassays in dignostics.

Order information

Catalog No.	Size	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-SMT-VPA-Ag	Size:1mg	756
GMP-SMT-VPA-Ag	Size:10mg	5292
GMP-SMT-VPA-Ag	Size:100mg	37044
GMP-SMT-VPA-Ab-1	Size:1mg	1953
GMP-SMT-VPA-Ab-1	Size:10mg	13671
GMP-SMT-VPA-Ab-1	Size:100mg	90160
GMP-SMT-VPA-Ab-2	Size:1mg	1953
GMP-SMT-VPA-Ab-2	Size:10mg	13671
GMP-SMT-VPA-Ab-2	Size:100mg	90160
GMP-SMT-VPA-Ag/Ab-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Cat No.	GMP-SMT-VPA-Ag
Product Name	BSA-Sodium valproate (VPA)
Expression platform	Synthetic
Bioactivity validation	Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Sodium valproate (VPA) with anti-Hapten antibody
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-SMT-VPA-Ab-1; GMP-SMT-VPA-Ab-2
Product Name	Anti- Sodium valproate (VPA) mouse monoclonal antibody (mAb)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	human Sodium valproate (VPA) binding, Competitive immunoassay validation (Competitive ELISA) in VPA level test and Epilepsy evaluation.
Tag	mFc
Products description	Anti- Sodium valproate (VPA) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
Specics	mouse
Purity	Purity: ≥95% （SDS-PAGE）
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.